The Israel Innovation Authority and the Ministry of Health today launched a dedicated regulatory sandbox for artificial intelligence technologies in healthcare. The move positions Israel among the first countries worldwide to establish a structured framework for testing autonomous AI systems in real clinical environments.
The first cohort includes three companies: Pulsenmore, Cordio Medical, and Simahook. The systems developed under the sandbox will be evaluated under tailored regulatory oversight, ensuring patient safety while providing rapid feedback from authorities.
Why It Matters
AI in healthcare is transitioning from decision-support tools to autonomous clinical care. Regulation must evolve accordingly to enable innovation while protecting the public. The new sandbox allows Israeli companies to test their technologies under controlled conditions and obtain approvals more efficiently.
This initiative reflects Israel's ongoing effort to maintain its leadership position in HealthTech and medical AI, areas where the country holds a significant competitive advantage.
The Bottom Line
The launch of the regulatory sandbox for medical AI represents an important step in the development of Israel's digital health ecosystem. It enables local companies to advance innovative solutions while meeting advanced regulatory standards.
